Y99-21213-50263
4 vaccinations
9 coded responses
52 check-ins
9 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 057 / VT
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
3HG-69351-67180
Child or adolescent in my care · Female · 2022-06-25
Timeline
-
2021-04-10
Registered in v-safe
-
2021-04-10
Dose 1 — Pfizer-BioNTech
-
2021-04-10
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, NauseaAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Muscle or body achesAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Joint pains, Muscle or body achesAdult check-in
- 2021-04-14
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-24
-
2021-05-01
Dose 2 — Pfizer-BioNTech
-
2021-05-01
Survey response — day 0, dose 2MedDRA: Dysgeusia — Feeling: Good · Site: Redness, Swelling · NauseaFree text: Metallic tasteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Redness · Joint painsAdult check-in
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-06
-
2021-05-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-05-08
- 2021-05-15
- 2021-05-23
- 2021-05-30
- 2021-06-05
- 2021-06-12
- 2021-08-02
- 2021-10-30
-
2021-11-02
Dose 3 — Pfizer-BioNTech
- 2021-11-02
-
2021-11-03
Survey response — days 1–6 daily, dose 3MedDRA: Dyspnoea, Respiratory tract congestion — Feeling: Fair · Site: Pain · Headache, Nausea, Rash, not including the immediate area around the injection siteFree text: Shortness of breath; congestionMedDRA releases: 2024-11 · check-in free text available
-
2021-11-04
Survey response — days 1–6 daily, dose 3MedDRA: Respiratory tract congestion — Feeling: Fair · Headache, Fatigue or tiredness, Rash, not including the immediate area around the injection siteFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
- 2021-11-05
-
2021-11-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, Muscle or body achesAdult check-in
-
2021-11-07
Survey response — days 1–6 daily, dose 3MedDRA: Respiratory tract congestion — Feeling: Good · FeverFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
-
2021-11-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-11-09
Health check-in — day 7, dose 3Feeling: Good · Site: Pain, Itching · Joint pains, Muscle or body achesAdult check-in
- 2021-11-16
- 2021-11-23
- 2021-11-30
- 2021-12-10
- 2021-12-20
-
2022-02-03
Survey response — 3 months, dose 3MedDRA: Breast pain, Musculoskeletal stiffness — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Pain in breast; stiff musclesMedDRA releases: 2024-11 · check-in free text available
-
2022-02-03
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-02-09
Call successfulParticipant prefers to complete VAERS report online
- 2022-05-03
-
2022-09-07
Dose 4 — Moderna
-
2022-09-07
Survey response — day 0, dose 4MedDRA: Dyspnoea — Feeling: Good · Site: Pain, Itching · Joint pains, Abdominal painFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
- 2022-09-08
-
2022-09-09
Health check-in — days 1–6 daily, dose 4Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2022-09-10
Survey response — days 1–6 daily, dose 4MedDRA: Dyspnoea — Feeling: Fair · Headache, Joint pains, NauseaFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
- 2022-09-11
- 2022-09-12
- 2022-09-21
- 2022-09-28
-
2022-10-05
Survey response — day 28, dose 4MedDRA: Cellulitis, Furuncle — Feeling: FairFree text: Boils and cellulitisMedDRA releases: 2024-11 · check-in free text available
- 2022-10-12
- 2022-10-22
-
2022-12-08
Survey response — 3 months, dose 4MedDRA: Gestational diabetes — Feeling: FairFree text: I am pregnant and was diagnosed with gestational diabetes.MedDRA releases: 2024-11 · check-in free text available
- 2023-03-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Pfizer-BioNTech | |
| 2 | 2021-05-01 | Pfizer-BioNTech | |
| 3 | 2021-11-02 | Pfizer-BioNTech | No |
| 4 | 2022-09-07 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-03 | Successful 2022-02-09 |
Participant prefers to complete VAERS report online |
Free text
Release 8 — day 0, dose 2
Systemic reaction (other): Metallic taste
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Shortness of breath; congestion
Systemic reaction (other): Congestion
Systemic reaction (other): Congestion
Release 11 — 3 months, dose 3
Symptoms: Pain in breast; stiff muscles
Release 12 — day 0, dose 4
Systemic reaction (other): Shortness of breath
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Shortness of breath
Release 12 — day 28, dose 4
Symptoms: Boils and cellulitis
Release 12 — 3 months, dose 4
Symptoms: I am pregnant and was diagnosed with gestational diabetes.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Breast pain | · | · | ✓ |
| SD | Cellulitis | · | · | ✓ |
| SD | Furuncle | · | · | ✓ |
| SD | Gestational diabetes | · | · | ✓ |
| SD | Musculoskeletal stiffness | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | · | · | ✓ |
| SRO | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release